CD86 and neoplasm: Moreover, further immunostained tumor tissues of lung metastasis nodules showed that treatment with NaHS led to a decrease in CD206 and an increase in CD86 in the GRP78‐WT group, but this effect was abrogated in the GRP78‐C420A group (Figure 6G).